Satoshi Osawa
Overview
Explore the profile of Satoshi Osawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Toyama C, Mizushima H, Kinjo K, Masunaga Y, Fujisawa Y, Miyairi I, et al.
Surg Case Rep
. 2024 Feb;
10(1):33.
PMID: 38302853
Background: Long tubular duplication is a rare congenital intestinal disease, that can lead to emergency situations marked by massive hemorrhage. However, preoperative diagnosis and surgical treatment are challenging. This report...
12.
Ishida N, Ito T, Takahashi K, Asai Y, Miyazu T, Higuchi T, et al.
World J Gastroenterol
. 2024 Jan;
29(47):6111-6121.
PMID: 38186681
Background: Although the usefulness of endoscopic scores, such as the Mayo Endoscopic Subscore (MES), Ulcerative Colitis Endoscopic Index of Severity (UCEIS), and Ulcerative Colitis Colonoscopic Index of Severity (UCCIS), and...
13.
Ishida N, Takahashi K, Asai Y, Miyazu T, Tamura S, Tani S, et al.
PLoS One
. 2024 Jan;
19(1):e0295681.
PMID: 38166010
Anti-tumor necrosis factor (TNF) -α antibodies, including infliximab (IFX), adalimumab (ADA), and golimumab, which were the first biologic therapeutic agents, have a crucial position in advanced therapy for ulcerative colitis...
14.
Murata M, Sugimoto M, Ueshima S, Nagami Y, Ominami M, Sawaya M, et al.
Gastrointest Endosc
. 2023 Dec;
99(5):721-731.e4.
PMID: 38042206
Background And Aims: Pharmacokinetic parameters, such as drug plasma level at trough, time to maximum plasma concentration (T), and coagulation factor Xa (FXa) activity generally predict factors for the anticoagulant...
15.
Kaneko M, Nakashima M, Sugiura K, Ishida N, Tamura S, Tani S, et al.
Medicine (Baltimore)
. 2023 Sep;
102(38):e35022.
PMID: 37746995
Although immunohistochemistry (IHC) for mismatch repair (MMR) proteins (MMR IHC) is used to identify DNA MMR status, universal screening of all patients with colorectal cancer (CRC) using a combination of...
16.
Sakurai T, Omori T, Tanaka H, Ito T, Ando K, Yamamura T, et al.
J Gastroenterol
. 2023 Jul;
58(10):1003-1014.
PMID: 37479808
Background: Evidence of small-bowel capsule endoscopy (SBCE) for evaluating lesions in Crohn's disease (CD) is lacking. We aimed to clarify the effectiveness and safety of SBCE in a large sample...
17.
Miyazu T, Ishida N, Asai Y, Tamura S, Tani S, Yamade M, et al.
World J Gastrointest Surg
. 2023 Jul;
15(6):1224-1231.
PMID: 37405109
Background: Primary sclerosing cholangitis (PSC) is an extraintestinal manifestation of ulcerative colitis (UC). PSC is a well-known risk factor for intrahepatic cholangiocarcinoma (ICC), and ICC is known to have a...
18.
Furuta T, Yamade M, Higuchi T, Takahashi S, Ishida N, Tani S, et al.
J Clin Med
. 2023 May;
12(9).
PMID: 37176551
Vonoprazan (VPZ) inhibits gastric acid secretion more potently than proton pump inhibitors. Recently, attention has been focused on the dual therapy with VPZ and amoxicillin (AMOX) for the eradication of...
19.
Kitajima H, Sakamoto T, Horie T, Kuwano A, Fuku A, Taki Y, et al.
Cells
. 2023 Jan;
12(2).
PMID: 36672268
Knee osteoarthritis (Knee OA) is an irreversible condition that causes bone deformity and degeneration of the articular cartilage that comprises the joints, resulting in chronic pain and movement disorders. The...
20.
Matsuura T, Hamaya Y, Onoue S, Tamura S, Ishida N, Yamade M, et al.
PLoS One
. 2023 Jan;
18(1):e0280279.
PMID: 36608042
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is one of the most serious complications of ERCP. Various procedures can reduce the incidence of PEP, such as wire-guided cannulation, prophylactic pancreatic...